Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Nurix Therapeutics Inc (NRIX)

209 + Investors. Track Smart Money conviction in NRIX. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +22
Streak
4Q ▲
Buyers last Q
56%

Smart Money Signals — NRIX

Based on 212 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 4 quarters in a row

last 6Q
For 4 consecutive quarters, more hedge funds added NRIX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
212 hedge funds hold NRIX right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +30% more funds vs a year ago

fund count last 6Q
+49 new funds entered over the past year (+30% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡

Slight buying edge — 56% buying

117 buying92 selling
Last quarter: 117 funds bought or added vs 92 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
📈

More new buyers each quarter (+11 vs last Q)

new funds entering per quarter
Funds opening a new NRIX position: 33 → 41 → 40 → 51. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

44% of holders stayed for 2+ years

■ 44% conviction (2yr+) ■ 27% medium ■ 29% new
93 out of 212 hedge funds have held NRIX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Value +57% but shares only +2% — price-driven

Value
+57%
Shares
+1%
Last quarter: the total dollar value of institutional holdings rose +57%, but actual share count only changed +2%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
📈

Growing discovery — still being found

27 → 33 → 41 → 40 → 51 new funds/Q
New funds entering each quarter: 33 → 41 → 40 → 51. A growing number of institutions are discovering NRIX each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Veteran-anchored — 53% veterans vs 31% newcomers

■ 53% veterans ■ 16% 1-2yr ■ 31% new
Entry-cohort mix of 216 holders: 114 (53%) are 2+ year veterans, 35 entered 1–2 years ago, and 67 (31%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
✅

Strong quality — 36% AUM from major funds

36% from top-100 AUM funds
44 of 211 holders rank in the top 100 by AUM, accounting for 36% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
4.1
out of 10
Moderate Exit Risk
Exit risk score 4.1/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — NRIX

In 2026 Q2, 117 hedge funds were net buyers of NRIX (51 opened a new position, 66 added to an existing one), while 92 reduced or exited (63 trimmed, 29 sold completely) — a 56% buyer ratio, indicating a slight buying edge. This marks 4 consecutive quarters of net institutional buying — a persistent conviction signal. 36% of total institutional value in NRIX is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +22 funds (more new holders than closures). Total institutional holders: 212.

Hedge Fund Ownership: NRIX

How many hedge funds hold NRIX — quarterly history vs. share price
Quarterly hedge fund ownership of NRIX vs. share price

Market Analysis: NRIX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: NRIX

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Nurix Therapeutics Inc (NRIX) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much NRIX has moved relative to its sector benchmark (XLV) since the 2026 Q3 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End September 30, 2026 · 45d ago
NRIX
-34.2%
XLV
+11.8%

NRIX outperformed XLV by -46.0% since September 30, 2026.

Since 13F Filing Date November 14, 2026 · 0d ago
NRIX
+0.0%
XLV
+0.0%

Since the filing became public, NRIX outperformed XLV by +0.0% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

12 top-rated funds 5 high-conviction
Consensus
4.8
/ 10
breadth
×
Elite
4.3
/ 10
conviction
Hedge Fund Positioning: NRIX
2026 Q3 Stats Unlock in 5 days 209 + Investors

Track Smart Money conviction in NRIX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 209 190 10.0%
13F Shares 117M 117M 0.11%
Total Value $2.69B $1.75B 53.49%
New Positions 51 40 +11
Increased Positions 64 65 -1
Closed Positions 31 30 +1
Reduced Positions 62 43 +19
Total Calls 3 2 50.0%
Total Puts 2 1 100.0%
PUT/CALL Ratio 0.67 0.5 Bullish

Statistics: NRIX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q3)

209 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in NRIX. Verified SEC 13F-HR filings.

QUARTER:
2026 Q3 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.
Top 25 NRIX holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 HighVista Strategies LLC 1.38% 221,026 $5.2M
2 Rhenman & Partners Asset Management AB 1.15% 439,500 $10.4M
3 WestHill Financial Advisors, Inc. 0.83% 208,333 $4.9M
4 AlphaCentric Advisors LLC 0.57% 27,006 $640K
5 Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group 0.43% 85,000 $2.0M
6 Kennedy Capital Management LLC 0.34% 753,465 $17.9M
7 Amova Asset Management Americas, Inc. 0.25% 863,077 $20.4M
8 ARK Investment Management LLC 0.25% 1,852,587 $43.9M
9 PSP Research LLC 0.20% 12,000 $285K
10 IQ EQ FUND MANAGEMENT (IRELAND) Ltd 0.16% 109,757 $2.6M
11 Emerald Investment Advisers, LLC 0.14% 84,159 $2.0M
12 Polymer Capital Management (HK) LTD 0.13% 58,898 $1.4M
13 Virtus Investment Advisers, LLC 0.10% 18,722 $444K
14 RAM Investment Partners, LLC 0.06% 17,284 $410K
15 F/m Investments LLC 0.06% 84,259 $2.0M
16 Jasper Ridge Partners, L.P. 0.06% 95,711 $2.3M
17 Penn Capital Management Company, LLC 0.06% 32,983 $782K
18 Clear Wave Wealth Management LLC 0.04% 10,792 $256K
19 Candriam S.C.A. 0.04% 371,262 $8.8M
20 Persistent Asset Partners Ltd 0.04% 5,573 $132K
21 Edmond de Rothschild Holding S.A. 0.03% 90,000 $2.1M
22 Pictet Asset Management Holding SA 0.03% 1,130,453 $26.8M
23 China Universal Asset Management Co., Ltd. 0.02% 18,936 $448K
24 Profund Advisors LLC 0.02% 34,133 $809K
25 Campbell & CO Investment Adviser LLC 0.02% 19,752 $468K
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Nurix Therapeutics Inc (NRIX)

What does the Smart Money Trend signal show for NRIX?

Buying streak — 4 quarters in a row: For 4 consecutive quarters, more hedge funds added NRIX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for NRIX?

Slight buying edge — 56% buying: Last quarter: 117 funds bought or added vs 92 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for NRIX holders?

Strong quality — 36% AUM from major funds: 44 of 211 holders rank in the top 100 by AUM, accounting for 36% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held NRIX?

44% of holders stayed for 2+ years: 93 out of 212 hedge funds have held NRIX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Nurix Therapeutics Inc (NRIX) following the 2026 Q3 hedge fund 13F filings?

As of today, NRIX has moved +0.0% since the 2026 Q3 13F filing date (November 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (September 30, 2026), NRIX has gained -34.2% vs +11.8% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →